医学
甲状腺
甲状腺癌
甲状腺癌
髓腔
肿瘤科
内科学
癌症研究
病理
原癌基因蛋白质c-ret
甲状腺髓样癌
内分泌学
受体
神经营养因子
胶质细胞源性神经生长因子
作者
Lori J. Wirth,Eric J. Sherman,Bruce Robinson,Benjamin Solomon,Hyunseok Kang,Jochen H. Lorch,Francis P. Worden,Marcia S. Brose,Jyoti D. Patel,Sophie Leboulleux,Yann Godbert,Fabrice Barlési,John C. Morris,Taofeek K. Owonikoko,Daniel S.W. Tan,Oliver Gautschi,Jared Weiss,Christelle de la Fouchardière,Mark E. Burkard,Janessa Laskin
标识
DOI:10.1056/nejmoa2005651
摘要
RET mutations occur in 70% of medullary thyroid cancers, and RET fusions occur rarely in other thyroid cancers. In patients with RET-altered thyroid cancers, the efficacy and safety of selective RET inhibition are unknown.
科研通智能强力驱动
Strongly Powered by AbleSci AI